The management of recurrent idiopathic priapism

Current Opinion in Urology

Volumn 7, Issue 6, 1997, Pages 354-358

  Kim, Fernando J ^a   Mulhall, John P ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; DIGOXIN; GONADORELIN AGONIST; PHENYLEPHRINE; TERBUTALINE;

DISEASE CLASSIFICATION; HUMAN; INTRACAVERNOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PENIS ERECTION; PRIAPISM; PRIORITY JOURNAL; REVIEW; SEXUAL FUNCTION;

EID: 0030813779     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-199711000-00009     Document Type: Review

References (27)

1. Mulhall JP, Honig S: Emergency management of priapism. Acad Emerg Med 1996, 3:810-816.
2. Papadopuolos I, Kelami A: Priapus and priaplsm: from mythology to medicine. Urology 1988, 32:385-386.
3. Krane RJ, Goldstein I, Saenz de Tejada I: Impotence. N Engl Med J 1989, 321:1648-1659.
4. Junemann KP, Persson-Junemann C, Alken P: Pathophysiology of erectile dysfunction. Semin Urol 1990, 8:80-93.
5. Garcia-Reboll L, Mulhall JP, Goldstein I: New drug delivery systems in impotence. Drugs Aging, 1997 (in press).
6. Lue TF, McAninch J, Tanagho E: Priapism: a refined approach to diagnosis and treatment. J Urol 1986, 136:104-108.
7. Levine F, Payton T, Goldstein I: Recurrent prolonged erections and priapism as a sequelae of priapism: pathophysiology and management. J Urol 1991, 145:764-767.
8. 2+ homeostasis. Moreover, the authors suggest that the reduced contractility of trabecular smooth muscle may be a significant factor in the perpetuation of the ischemic state.
9. Bastuba MD, Saenz de Tejada I, Dinclenc CZ, Sarazen A, Krane RJ, Goldstein I: Arterial priapism: diagnosis, treatment and long-term follow-up. J Urol 1994, 151:1231-1237.
10. Witt M, Goldstein I, Saenz de Terada I, Greenfield A, Krane RJ: Traumatic laceration of intracavernosal arteries: the pathophysiology of non-ischemic, high flow, arterial priapism. J Urol 1990, 143:129-133.
11. Pohl J, Pott B, Kleinhaus G: Priapism: a three-phase concept of management according to etiology and prognosis. Br J Urol 1986, 58:113-116.
12. Abber JC, Lue TF, Luo JA, Junemann, KP, Tanagho EA: Priapism induced by chlorpromazine and trazadone. J Urol 1987, 137:1039-1040.
13. Lance R, Albo M, Costabile RA, Steers W: Oral trazadone as empirical therapy for erectile dysfunction: a retrospective review. Urology 1995, 46:117-120.
14. Banos JE, Bosch F, Farre M: Drug-induced priapism: etiology, incidence and treatment. Med Toxicol 1989, 4:46-50.
15. Hamre MR, Harmin EP, Kirkpatrick DV, Stern MJ, Humbert JR: Priapism as a complication of sickle cell disease. J Urol 1991, 145:1-4.
16. Edmond A, Hayes R, Serjeant G: Priapism and impotence in homozygous sickle cell disease. Arch Intern Med 1980, 140:1434-1437.
17. Winter CC: Priapism. J Urol 1981, 125:212-214.
18. Sadeghi-Nejad H, Gupta S, Salimpour P, Daller M, Krane R, Goldstein I: Treatment of recurrent veno-occluslve priapism by digoxin [Abstract]. J Urol 1997, 157:202.
19. Hakim LS, Kulaksizoglu H, Mulligan R, Greenfield A, Goldstein I: Evolving concepts in the management of arterial priapism. J Urol 1996, 155:541-548. This paper gives a comprehensive account of the current 'state-of-the-art' evaluation and management of arterial priapism.
20. Fowler JE, Koshy M, Strub M, Chinn SK: Priaplsm associated with sickle cell hemoglobinopathies: prevalence, natural history and sequelae. J Urol 1991, 145:65-68.
21. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB: Impotence and its medical and psychological correlates: results of Massachusetts male aging study. J Urol 1994, 151:54-61.
22. Gupta S, Moreland RB, Munarriz R, Daley J, Goldstein I, Saenz de Tejada L: Possible role of Na-K-ATPase in the regulation of human corpus cavernosum smooth muscle contractility by nitric oxide. Br J Pharmacol 1995, 116:2201-2206.
23. +-ATPase activity in penile tumescence and the ability of digoxin to inhibit this mechanism.
24. 1-induced prolonged erections. Urology 1993, 42:51-53.
25. Shanta TR, Finnerty DR, Rodriguez AP: Treatment of persistent erection and priapism using terbutaline. J Urol 1989, 141:1427-1428
26. Levine LA, Guss SP: Gonadotropin-releasing hormone analogues In the treatment of sickle cell anemia-associated priapism. J Urol 1993, 150:455-457.
27. Ra S, Fujioka T, Sato F, Kubo T, Yasuda N: In vitro contraction of the canine corpus cavernosum penis by direct perfusion with prolactin or growth hormone. J Urol 1996, 156:522-525.